Ofatumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about GlobalPharmacyMeds.to
List of countries where we can ship Ofatumumab:
Latest news releases on Ofatumumab:
Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.
The purpose of the study is to evaluate whether treatment with ibrutinib as a monotherapy results in a clinically significant improvement in progression free survival ...
Background In patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL), a short duration of response to therapy or adverse cytogenetic ...
Ofatumumab in Rituximab-Allergic TTP A patient with refractory thrombotic thrombocytopenic purpura had anaphylaxis associated with rituximab that was mediated by ...
The U.S. Food and Drug Administration (FDA) has approved changes to the prescribing information of the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab ...
Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia
Nutzenbewertungsverfahren zum Wirkstoff Idelalisib (neues Anwendungsgebiet: chronische lymphatische Leukämie in Kombination mit Ofatumumab)
Discover the Novartis pipeline of over 200 projects in clinical development, many for medicines that could advance treatment standards for patients.
the most important information i should know about rituxan: infusion reactions, severe skin and mouth reactions, hepatitis b virus (hbv) reactivation and progressive ...
Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.